Renal replacement therapy neutralizes elevated MIF levels in septic shock.

Area of Science:

• Critical Care Medicine
• Immunology
• Nephrology

Background:

• Macrophage migration inhibitory factor (MIF) amplifies immune responses in sepsis, but clinical data on its role in septic patients are limited.
• Renal replacement therapy (RRT) is explored for cytokine removal in sepsis.
• MIF removal by RRT in chronic kidney disease suggests potential for septic shock patients.

Purpose of the Study:

• To investigate if RRT can lower plasma levels of the pro-inflammatory cytokine MIF in septic shock patients.
• To assess the impact of continuous RRT (CRRT) on MIF levels and mortality in septic shock with acute kidney injury (AKI).

Main Methods:

• Observational, single-center study in an ICU involving 25 septic shock patients.
• Assessed plasma MIF levels and mortality using a validated method.
• Compared MIF levels and mortality between patients with and without CRRT for septic AKI.

Main Results:

• CRRT significantly decreased plasma MIF levels in septic shock patients with AKI, indicating MIF removal by hemodialysis.
• Patients undergoing CRRT showed lower MIF release (MIFAUC) and distinctly lower mortality.
• Higher MIF levels and MIFAUC were associated with non-survival in septic shock.

Conclusions:

• This study demonstrates efficient MIF removal from plasma in septic shock patients via CRRT.
• Reduction of circulating MIF by CRRT correlated with improved survival.
• Targeted MIF removal may be a promising therapeutic strategy to reduce mortality in severe sepsis.